EP Patent

EP4056186A1 — Pharmaceutical composition comprising drospirenone and contraceptive kit

Assigned to Laboratorios Leon Farma SA · Expires 2022-09-14 · 4y expired

What this patent protects

The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokin…

USPTO Abstract

The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokinetic profile. The use of the said composition in contraceptive methods and kits are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP4056186A1
Jurisdiction
EP
Classification
—
Expires
2022-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Laboratorios Leon Farma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.